---
figid: PMC5408465__nihms855762f1
figlink: /pmc/articles/PMC5408465/figure/F1/
number: F1
caption: The role of calmodulin (CaM) with phosphorylated tyrosine 99 (pTyr99) in
  KRAS-driven adenocarcinoma. In physiological cell growth, receptor tyrosine kinase
  (RTK) signal activates phosphatidylinositol 3-kinase (PI3K) through binding of the
  RTK’s pYXXM motif to the n/cSH2 domains of the p85 subunit of PI3Kα. In KRAS-driven
  adenocarcinomas, CaM with pTyr99 acts by fully activating PI3Kα through binding
  of the pTyr99 to the two SH2 domains of PI3Kα. The CaM’s pTyr99 binding site acts
  as the RTK’s pYXXM motif, substituting the missing RTK signal, thus stimulating
  the PI3Kα/Akt/mTOR pathway.
pmcid: PMC5408465
papertitle: Calmodulin and PI3K Signaling in KRAS Cancers.
reftext: Ruth Nussinov, et al. Trends Cancer. 2017 Mar;3(3):214-224.
pmc_ranked_result_index: '131590'
pathway_score: 0.8909138
filename: nihms855762f1.jpg
figtitle: Calmodulin (CaM) with phosphorylated tyrosine 99 (pTyr99) in KRAS-driven
  adenocarcinoma
year: '2017'
organisms: Homo sapiens
ndex: 57363650-de97-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5408465__nihms855762f1.html
  '@type': Dataset
  description: The role of calmodulin (CaM) with phosphorylated tyrosine 99 (pTyr99)
    in KRAS-driven adenocarcinoma. In physiological cell growth, receptor tyrosine
    kinase (RTK) signal activates phosphatidylinositol 3-kinase (PI3K) through binding
    of the RTK’s pYXXM motif to the n/cSH2 domains of the p85 subunit of PI3Kα. In
    KRAS-driven adenocarcinomas, CaM with pTyr99 acts by fully activating PI3Kα through
    binding of the pTyr99 to the two SH2 domains of PI3Kα. The CaM’s pTyr99 binding
    site acts as the RTK’s pYXXM motif, substituting the missing RTK signal, thus
    stimulating the PI3Kα/Akt/mTOR pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - PDK3
  - EGFR
  - MTOR
  - CA2
  - CSH2
  - PDK4
  - PDK1
  - RPTOR
  - AKT1
  - AKT3
  - PDK2
  - SART3
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Ca2+/Calmodulin-dependentPI3KaActivation
  symbol: CA-II
  source: hgnc_alias_symbol
  hgnc_symbol: CA2
  entrez: '760'
- word: CSH2
  symbol: CSH2
  source: hgnc_symbol
  hgnc_symbol: CSH2
  entrez: '1443'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
chemicals: []
diseases: []
figid_alias: PMC5408465__F1
redirect_from: /figures/PMC5408465__F1
figtype: Figure
---
